Search
Search Results
-
Anti-arrhythmic Drugs—a Review and Comment on Relevance in the Current Era: Part 1
Purpose of reviewThere is apprehension and a general lack of familiarity with regard to using the ionic channel specific anti-arrhythmic agents among...
-
Characteristics of patients with atrial flutter and spontaneous 1:1 atrioventricular conduction with and without anti-arrhythmic drug treatment
Atrial flutter (AFL) is a large reentrant circuit located in the right atrium. Anti-arrhythmic drugs (AADs) can provoke AFL with 1:1 atrioventricular...
-
-
The Efficacy of Anti-Arrhythmic Drugs in Children With Idiopathic Frequent Symptomatic or Asymptomatic Premature Ventricular Complexes With or Without Asymptomatic Ventricular Tachycardia: a Retrospective Multi-Center Study
The aim of the study is to compare the efficacy of flecainide, beta-blockers, sotalol, and verapamil in children with frequent PVCs, with or without...
-
Novel Pulmonary Delivery of Drugs for the Management of Atrial Fibrillation
Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia, affecting approximately 335 million patients worldwide. Comprehensive...
-
Gut microbiota and cardiac arrhythmia: a pharmacokinetic scope
BackgroundDealing with cardiac arrhythmia is a difficult challenge. Choosing between different anti-arrhythmic drugs (AADs) while being cautious...
-
Rediscover the predictive capacity of B-type natriuretic peptide applied to neonatal supraventricular tachycardia
BackgroundSupraventricular tachycardia (SVT) is one of the most common non-benign arrhythmias in neonates, potentially leading to cardiac...
-
Has COVID-19 changed the spectrum of arrhythmias and the incidence of sudden cardiac death?
Arrhythmic manifestations of COVID-19 include atrial arrhythmias such as atrial fibrillation or atrial flutter, sinus node dysfunction,...
-
Designing combinational herbal drugs based on target space analysis
BackgroundTraditional oriental medicines (TOMs) are a medical practice that follows different philosophies to pharmaceutical drugs and they have been...
-
Effectiveness and safety of IL1 inhibition with anakinra in chronic refractory idiopathic myocarditis
AimThe aim of this study was to evaluate the effectiveness and safety of the anti-IL-1 receptor anakinra in patients with chronic active myocarditis...
-
SGLT2 inhibitors and the cardiac rhythm: unraveling the connections
Sodium-glucose co-transporter 2 inhibitors (SGLT2is), primarily used for managing type 2 diabetes mellitus, have recently gained attention for their...
-
COVID-19 and Cardiac Arrhythmias: a Contemporary Review
Purpose of ReviewA significant proportion of patients infected by the severe acute respiratory syndrome-coronavirus (SARS-CoV2) (COVID-19) also have...
-
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
Despite treatment with statins, patients with elevated low-density lipoprotein cholesterol (LDL-C) and triglycerides remain at increased risk for...
-
Inflammation and arrhythmogenesis: a narrative review of the complex relationship
BackgroundA biological mechanism called inflammation is necessary for reacting to damaging stimuli, but it can also, ironically, play a role in the...
-
Dose Recommendations for Common Drugs in Patients with Liver Cirrhosis: A Systematic Literature Review
Background and ObjectivesThe presence of liver cirrhosis affects the selection and dosing of drugs metabolised by the liver as doses have to be...
-
Pulsed field ablation in real-world atrial fibrillation patients: clinical recurrence, operator learning curve and re-do procedural findings
BackgroundPulsed field ablation (PFA) is a novel method of cardiac ablation demonstrated in early pre-clinical and clinical settings. The aim of this...
